Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
63.6M
-
Number of holders
-
164
-
Total shares
-
42.7M
-
Shares change
-
+4.03M
-
Total reported value, excl. options
-
$3.22B
-
Value change
-
+$300M
-
Put/Call ratio
-
0.3
-
Number of buys
-
109
-
Number of sells
-
-51
-
Price
-
$75.41
Significant Holders of Blueprint Medicines Corp - Common Stock (BPMC) as of Q4 2017
171 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock as of Q4 2017.
Blueprint Medicines Corp - Common Stock (BPMC) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.7M shares
of 63.6M outstanding shares and own 67.16% of the company stock.
Largest 10 shareholders include FMR LLC (6.43M shares), Vanguard Group Inc (3.32M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.31M shares), BlackRock Inc. (3.08M shares), WELLINGTON MANAGEMENT GROUP LLP (2.47M shares), TRV GP II, LLC (2.45M shares), LORD, ABBETT & CO. LLC (1.78M shares), OppenheimerFunds, Inc. (1.63M shares), STATE STREET CORP (1.5M shares), and Hillhouse Capital Management, Ltd. (1.37M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.